New study results suggest Verdure Sciences’ Pomella pomegranate extract may improve cardiovascular-health markers in patients with myocardial infarction.
Photo © iStockphoto.com/© Alexei Zaycev
New study results1 out of India suggest Pomella, a pomegranate extract from Verdure Sciences (Noblesville, IN), may improve several cardiovascular-health markets in patients with myocardial infarction, including significant improvements to cholesterol levels.
For 30 days, 100 participants aged 20–60 with myocardial infarction were assigned to consume either a placebo or 300 mg/day of Pomella twice daily in addition to their regular prescribed medications. Compared to cardiac biomedical parameters assessed at baseline, researchers found that the Pomella group experienced significant improvements in mean levels of total cholesterol, LDL cholesterol, and HDL cholesterol at the end of the study period, with an observed increase in HDL cholesterol and a decrease in LDL cholesterol. Meanwhile, mean levels of triglycerides, serum homosystein, hs-CRP, and OX-LDL all showed significant improvements in the experimental group after participants added Pomella to their regular medication regimens for 30 days.
Verdure Sciences also noted that a separate study2, which was conducted by the same group of researchers, recently found that Pomella extract may significantly reduce blood glucose levels and HbA1C levels in patients with type 2 diabetes and myocardial infarction. That study asked 40 participants aged 20–55 to consume either 300 mg/day of Pomella or a placebo for 30 days, also in addition to their prescribed medication.
“We are very excited to see the additional support of Pomella’s efficacious capabilities and potential health applications,” said Sonya Cropper, vice president of marketing and innovation with Verdure Sciences, in an announcement of the study results. “It is impressive to see the impact Pomella has on biomarkers that influence health in these complementary clinical trials.”
Read more:
Pomegranate Metabolite Improves Mitochondrial and Muscle Function?
Coke Cleared by Jury in Advertising Lawsuit Brought by POM Wonderful
8 New Functional Food Innovations
Michael Crane
Associate Editor
Nutritional Outlook Magazine
michael.crane@ubm.com
1. Goyal R et al., “An antixoidative effect of Punica granatum (pomegranate) on biochemical parameters in patients with myocardial infarction: a double blind placebo controlled trial,” European Journal of Biomedical and Pharmaceutical Sciences, vol. 3, no. 5 (2016): 662–667
2. Goyal R et al., “Antixoidative effect of Puica granatum (pomegranate) on biochemical parameters in patients with diabetes mellitus (type 2) and myocardial infarction: a double blind placebo controlled trial,” International Journal of Advanced Research, vol. 4, no. 5 (2016): 857–864
Cracking the code: Advancements in calcium absorption and nutritional understanding
July 23rd 2024Recent research conducted by ILSI U.S. and Canada – a global, nonprofit federation dedicated to advancing precompetitive research in the food, nutrition and health realms – and partially funded by Balchem, has shed light on how to improve predictions of Ca bioavailability across different food matrices.
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.